About Lisa Foster

Articles by Lisa Foster

What You Need To Know About Cardiovascular-Kidney-Metabolic Syndrome
Aug 23, 2024
Pain And Follicular Lymphoma
Aug 22, 2024
What If My CAR-T Therapy Fails?
Aug 16, 2024
$Testing A New Drug Combination For Relapsed/Refractory Multiple Myeloma image$

Testing A New Drug Combination For Relapsed/Refractory Multiple Myeloma
Aug 12, 2024
What Are the Types of Secondary Myelofibrosis?
Aug 05, 2024
Bendamustine to Treat Follicular Lymphoma
Jul 22, 2024
Smoldering Myeloma: What We Know And Where We’re Going
Jul 16, 2024
Metformin: A Potential Ally Against Developing Myeloproliferative Neoplasms
Jul 14, 2024
How Race and Financial Status Can Affect Access to CAR T-Cell Therapies Approved for Patients with B-cell Lymphoma
Jul 12, 2024
$EHA 2024: Golcadomide Alone or Combined with Rituximab in Relapsed/Refractory Follicular Lymphoma image$

EHA 2024: Golcadomide Alone or Combined with Rituximab in Relapsed/Refractory Follicular Lymphoma
Jul 09, 2024
Diagnosed With High-Risk Myeloma, What Now?
Jul 08, 2024
How Does Outdoor Air Pollution Affect Myeloma?
Jul 03, 2024
Everything You Need to Know About DLBCL
Jul 03, 2024
Managing Smoldering Multiple Myeloma: Current Approaches and Ongoing Research
Jul 02, 2024
Frequently Asked Questions About Lymphoma: B vs. T Cells
Jun 27, 2024
Skin Lesions and MDS
Jun 27, 2024
What Is A Chemo Port?
Jun 26, 2024
SuPAR And Kidney Inflammation
Jun 25, 2024
Diffuse Large B-Cell Lymphoma: Your Essential Questions Answered
Jun 20, 2024
Imelelstat Approved For Lower-Risk MDS: New Hope for Transfusion-Dependent MDS Patients
Jun 12, 2024
Ziftomenib: A Promising New Drug For NPM1 AML
Jun 12, 2024
Relapsed DLBCL Treatment Options: Exploring Loncastuximab Tesirine (Zynlonta)
May 31, 2024
The MANIFEST 2 Trial: Pelabresib and Ruxolitinib
May 22, 2024
The Use of Bispecifics and CAR-T in Myeloma Treatment
May 21, 2024